iNtRON Biotechnology, Inc. (KOSDAQ:048530)
South Korea · Delayed Price · Currency is KRW 4,560.00
-120.00 (-2.56%)
Mar 12, 2026, 2:15 PM KST
iNtRON Biotechnology Market Cap
iNtRON Biotechnology has a market cap or net worth of 143.46 billion as of March 11, 2026. Its market cap has decreased by -15.35% in one year.
Market Cap
143.46B
Enterprise Value
108.54B
Revenue
5.56B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,560.00
Market Cap Chart
Since January 26, 2011, iNtRON Biotechnology's market cap has increased from 95.30B to 143.46B, an increase of 50.54%. That is a compound annual growth rate of 2.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 143.46B | 39.63% |
| Dec 30, 2025 | 102.75B | -44.03% |
| Dec 30, 2024 | 183.56B | -37.01% |
| Dec 28, 2023 | 291.42B | 7.98% |
| Dec 29, 2022 | 269.88B | -61.99% |
| Dec 30, 2021 | 710.00B | -22.41% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLB Therapeutics | 240.12B |
| EASY BIO,Inc. | 229.92B |
| Genexine | 223.76B |
| Vaxcell-Bio Therapeutics | 182.11B |
| Macrogen | 177.58B |
| ENCell | 172.47B |
| MedPacto | 164.52B |
| CG Invites | 110.04B |